Moleculin Biotech - 53 Year Dividend History | MBRX
Historical dividend payout and yield for Moleculin Biotech (MBRX) since 1971. The current TTM dividend payout for Moleculin Biotech (MBRX) as of December 20, 2024 is $0.00. The current dividend yield for Moleculin Biotech as of December 20, 2024 is 0.00%.
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Biomedical and Genetics |
$0.007B |
$0.000B |
|
Moleculin Biotech, Inc. is a preclinical and clinical-stage pharmaceutical company which focused on the development of anti-cancer drug candidates. The company's lead product candidate is Annamycin, a Phase II clinical stage anthracycline for the treatment of relapsed or refractory acute myeloid leukemia. Moleculin Biotech, Inc. is based in Houston, TX.
|
| Stock Name |
Country |
Market Cap |
PE Ratio |
